ARCHIVES

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

This article is from The Cancer Letter archive.

Vol. 38 No. 02 | January 13, 2012

Download PDF Visit The Full Archive

Related Articles

‘Interactive Research Project Grants’ Proposed, Goal To Provide Step Between R01s and P01s

October 25, 1991

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000